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Abstract 
Background: The acquisition of reliable tissue-specific RNA sequencing data from human skin biopsy represents 
a major advance in research. However, the complexity of the process of isolation of specific layers from fresh-frozen 
human specimen by laser capture microdissection, the abundant presence of skin nucleases and RNA instability 
remain relevant methodological challenges. We developed and optimized a protocol to extract RNA from layers of 
human skin biopsies and to provide satisfactory quality and amount of mRNA sequencing data.
Results: The protocol includes steps of collection, embedding, freezing, histological coloration and relative optimiza-
tion to preserve RNA extracted from specific components of fresh-frozen human skin biopsy of 14 subjects. Optimi-
zation of the protocol includes a preservation step in  RNALater® Solution, the control of specimen temperature, the 
use of RNase Inhibitors and the time reduction of the staining procedure. The quality of extracted RNA was measured 
using the percentage of fragments longer than 200 nucleotides  (DV200), a more suitable measurement for success-
ful library preparation than the RNA Integrity Number (RIN). RNA was then enriched using the  TruSeq® RNA Access 
Library Prep Kit  (Illumina®) and sequenced on  HiSeq® 2500 platform  (Illumina®). Quality control on RNA sequencing 
data was adequate to get reliable data for downstream analysis.
Conclusions: The described implemented and optimized protocol can be used for generating transcriptomics data 
on skin tissues, and it is potentially applicable to other tissues. It can be extended to multicenter studies, due to the 
introduction of an initial step of preservation of the specimen that allowed the shipment of biological samples.
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Background
The ability to generate tissue-specific expression profiles 
can significantly expand our knowledge on the patho-
physiological mechanisms of different diseases, provid-
ing information on functional elements and molecular 
constituents of the tissues and identifying new diagnostic 
and therapeutic biomarkers [1]. High-throughput gene 
expression profiling through next generation sequencing 
(NGS) has several advantages over microarray technol-
ogy, such as single-nucleotide resolution and the pos-
sibility to study the entire RNA content of a single cell, 
cell populations or tissues starting from nanograms 
quantities of input material [2, 3]. Moreover, by assaying 
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millions of transcripts in RNA sequencing data, it is also 
possible to discover gene fusion, alternative splicing and 
novel isoforms expanding the complexity of gene expres-
sion field not possible with microarray technology [1, 2].
To study tissue-specific expression profile, the first step 
is the isolation of the biological source. The laser capture 
microdissection (LMD) technology allows the isolation of 
cells of interest morphologically identified via microscopic 
visualization. It can minimize the hurdle of tissue heteroge-
neity observed in homogenates of whole tissues [4, 5], allow-
ing genomics, transcriptomics, and proteomics studies on 
accurately isolated target cells [5]. To successfully capture the 
sample of interest, the preparation of the specimen is funda-
mental [6] and needs to be methodologically implemented to 
obtain sufficient amount of RNA of high quality from micro-
dissected fresh tissue for an accurate expression profiling 
[7–12]. Although different commercially available kits can 
be employed to extract RNA from microdissected sections 
[6], RNA preservation can be affected by the microdissection 
phase, the extraction procedures and the presence of nucle-
ases in aqueous solutions or in tissues [7–10].
In the present paper, we describe an optimized pro-
tocol starting from human skin biopsy collection at the 
distal leg up to the final step of RNA extraction from 
layers of fresh-frozen sections microdissected by LMD. 
We implemented several optimizations to overcome the 
problems related to the high instability of RNA molecule, 
the presence of high amounts of nucleases in the skin and 
the many steps necessary for biopsy processing, improv-
ing the quality of extracted RNA. Moreover, we intro-
duced an initial step of immersion of the specimen into 
 RNALater® preserving solution (Applied Biosystems, 
Foster City, CA, USA), making this protocol suitable also 
for multicenter studies in which biological specimens 
need to be collected by different centers and shipped for 
future processing in a central laboratory, allowing its use 
in clinical and research studies.
Results
Subject recruitment
Eight patients (5 males and 3 females) affected by idi-
opathic sensory neuropathy (mean age ± standard 
deviation (SD): 63.4 ± 4.2  years), and six age-matched 
healthy controls (4 males and 2 females; mean age ± SD: 
53.8 ± 3.5  years) were recruited. Skin biopsies were col-
lected from the 14 subjects and preserved in  RNALater® 
solution at 4 °C for 1 week.
Cryosection, hematoxylin and eosin (H&E) staining 
and laser capture microdissection
We included the biopsies in Killik cryostat embedding 
OCT medium and, after the storage in liquid nitrogen 
for at least 1  week, we proceeded with the cryosection 
facilitated by liquid nitrogen flow. H&E staining was then 
performed modifying the protocol published by Yee and 
colleagues [9] to accelerate the staining time in order to 
preserve the integrity of the RNA.
Proceeding with the LMD, two-dimensional measure-
ments and numbers of collected areas were registered 
before cutting the selected area in order to calculate the 
volume of tissue from which RNA was extracted. The 
microdissected sections were the enriched layer of fib-
ers (ELF), the glands (G), the dermis (D) and the whole 
section (WS). The epidermis was not separately dissected 
from the biopsy but it was part of the ELF and of the WS. 
A representative picture of the staining of the four tis-
sue components are shown in Fig. 1. As expected, whole 
section was the component with the highest area and 
volume, while the lowest quantity was represented by 
glands. Measurements are reported in Table  1 as mean 
value ± SD of all samples for all skin components. Over-
all, it was possible to dissect the glands in 9 subjects (6 
males, of which 4 patients and 2 healthy controls, 1 
female patient  and 2 female healthy controls) out of 14 
because they were not present in all the skin biopsies, 
while the other three layers were dissected in all subjects. 
RNA quantity measurements and quality assessment
Table  1 shows the average concentration and the total 
amount of RNA obtained for each tissue. The highest 
concentration and total amount of RNA were obtained 
from ELF and WS, with a mean RNA concentration ± SD 
of 3.7  ng/µl ± 2.7 from ELF, 2.0  ng/µl ± 0.1 from G, 
2.6  ng/µl ± 0.7 from D and 3.1  ng/µl ± 1.4 from WS (p: 
0.004 between ELF and G). As expected, the four tissues 
showed a similar degradation degree that was lower than 
non-degraded RNA (RIN > 7). In particular, the ELF and 
WS reported a mean RIN ± SD of 2.2 ± 0.4 and 2.6 ± 1.1 
respectively, while G and D of 1.4 ± 0.7 and 1.1 ± 0.3 
respectively (mean ± SD) (Table  1). A significant differ-
ence of RIN occurred between WS vs G (p value 0.01), 
and WS vs D and ELF vs D (p values < 0.0001). Since the 
extracted RNA was partially degraded, a more suitable 
measurement of degradation, the  DV200 metric defined as 
the percentage of RNA fragments longer than 200 nucle-
otides, was used to evaluate sample quality for the librar-
ies preparation according to Illumina technical note [13]. 
Except for three samples of D (sample 2, 9 and 11) and 
one of G (sample 10), with values ranging between 61 and 
67%, all samples reached a quality level of  DV200 ≥ 70% 
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(Additional file 1: Table S1). The mean value ± SD of all 
measurements are reported in Table  1, while in Addi-
tional file 1: Table S1 we presented the details of each sin-
gle sample.
Library generation and sequencing
As reported in Additional file  1: Table  S1, library prep-
aration was performed for 24 samples using 20  ng of 
extracted RNA following the manufacturer’s protocol, 
a
c
d
b
Fig. 1 Representation of the four skin components stained with hematoxylin and eosin. a whole section: b dermis; c enriched layer of fibers 
extending for 200–300 μm from the surface layer of the skin and d glands. Magnification: ×4 (a, b) and ×10 (c, d). Scale bar = 200 μm
Table 1 Measurements of microdissected skin area and extracted RNA
Summary of the number, area and volume of microdissected areas, RNA concentration, RNA Integrity Number (RIN) and percentage of fragments longer than 200 
nucleotides  (DV200) for all the samples in different skin components. All the values were reported as mean ± standard deviation (SD). ELF enriched layer of fibers, G 
glands, D dermis, WS whole section
Tissue ELF (n = 14) G (n = 9) D (n = 14) WS (n = 14)
Number of microdissected areas (n) 12.2 ± 3.6 5.9 ± 5.9 9.9 ± 2.1 8.6 ± 1.8
Microdissected area  (mm2) 1.1 ± 0.4 0.06 ± 0.07 1.6 ± 0.8 2.3 ± 1.1
Microdissected volume  (mm3) 0.02 ± 0.01 0.001 ± 0.001 0.03 ± 0.02 0.05 ± 0.02
Concentration (ng/μl) 3.7 ± 2.7 2.0 ± 0.1 2.6 ± 0.7 3.1 ± 1.4
RIN 2.2 ± 0.4 1.4 ± 0.7 1.1 ± 0.3 2.6 ± 1.1
DV200 (%) 87.7 ± 3.4 81.0 ± 6.3 79.4 ± 9.2 87.4 ± 5.7
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while for 27 samples the extracted amount was not suf-
ficient thus we used the maximum available amount 
(17–19  ng). Ten samples did not reach a cDNA con-
centration higher than 1  ng/μl, and they were excluded 
from the experiment. Their exclusion seems not be 
related to the input amount nor to the degree of degra-
dation (Additional file  1: Table  S1). As expected, a sig-
nificant positive correlation between input RNA and the 
yield of cDNA was confirmed by Spearman’s correlation 
analysis, as shown in Fig.  2a (p value: 0.031; beta: 7.56; 
 r2: 0.22). Unexpectedly, for 7 of 24 samples that fulfilled 
the requested input of RNA it was not possible to reach 
1 ng/µl of cDNA. On the contrary, for 24 out of 27 sam-
ples with a lower amount of input RNA, we obtained 
enough quantity of cDNA to proceed with the protocol. 
Hybridization occurred in multiplexed modality using 
200–30 ng of cDNA from each sample depending on the 
reached cDNA amount. In detail, the amount for pools 
preparation was calculated according to the sample with 
the lowest concentration within each pool in order to 
obtain homogeneous enriched samples. Additional file 1: 
Table  S1 reports the hybridized amount, the pooling 
strategy, and the final concentration of libraries. A signifi-
cant positive correlation between the pooled amount and 
the yield of libraries was confirmed by Spearman’s corre-
lation analysis, as shown in Fig. 2b (p value < 0.0001; beta: 
0.02;  r2: 0.52).
A number of reads between 21 and 35 million/sample 
was obtained in 16 samples, between 35 and 90 million 
reads/sample in 22 samples, and less than 20 million 
reads (ranging from 13.2 and 17.8 millions of reads) in 3 
samples (Additional file 1: Table S1).
Quality control of RNA sequencing data
In order to rule out potential batch effects caused by 
the types of samples and/or by the technique, the base 
sequence quality by cycle expressed with the Phred qual-
ity score (Q score) was evaluated and represented across 
tissue compartments (Additional file 2: Figure S1A) and 
flow cells (FC) (Additional file 2: Figure S1B). As shown 
in Additional file  2: Figures  S1A, B, the Q scores of the 
experiment ranged from 37 to 39.5, and the trend was 
similar across different conditions.
To further increase the homogeneity of data, we per-
formed a down-sampling, reducing samples with more 
than 45 million reads to 35 million. In Additional file 3: 
Figure S2 it is reported the density plot of log10-trans-
formed reads counts. The global trend was similar across 
samples, and it followed a Gaussian distribution.
The Principal Component Analysis (PCA) was per-
formed to identify potential outliers. Additional file  4: 
Figure S3 shows data projected onto the 3 principal com-
ponents (PCs), which account for approximately 43% of 
the overall variance of the dataset. As shown in Addi-
tional file  4: Figure S3, a degree of separation between 
ELF and WS and between G and D along the second PC 
was observed. Additionally, sample S7d could be deemed 
as a potential outlier along the first PC (that explains the 
largest variability across samples), and the sample S11g 
along the third PC (that explains a lower variability across 
samples).
Aligning the sequenced reads to the human reference 
genome, we reached a mean percentage of uniquely 
mapped reads of 83.2% ± 1.4 (mean ± SD) across ELF, WS 
and D while for glands it was 82.2% ± 3.7 (mean ± SD) 
(Additional file  5: Figure S4A). A trend of positive cor-
relation between the number of uniquely mapped reads 
and the  DV200 was confirmed by Spearman’s correla-
tion analysis, as shown in Additional file 5: Figure S4B (p 
value: 0.013; beta: 0.11;  r2: 0.15).
Fig. 2 RNA/cDNA and cDNA/library correlation. Correlation 
between the RNA input and the yield of cDNA obtained before the 
hybridization step (a; p: 0.031, beta: 7.56 and  r2: 0.22) and between 
the pooled amount used for cDNA hybridization and the yield of final 
libraries (b; p < 0.0001, beta: 0.02 and  r2: 0.52)
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To further confirm the reliability of generated data, we 
evaluated the expression of skin-enriched genes emerged 
from a transcriptomic and proteomic profiling study per-
formed in 2015 [14]. As shown in Fig.  3, for three rep-
resentative transcripts (COL17A1: Collagen Type XVII 
Alpha 1 Chain; DMKN Dermokine and KRT10: Keratin 
10), a higher expression was detected in all the four skin 
components compared to non-skin tissue (high quality 
RNA collected from whole blood of 20 subjects and pro-
cessed with the same sequencing protocol used for pro-
cessing the skin components) (p < 0.001). A similar trend 
was obtained for other analyzed skin-related genes (data 
not shown).
Discussion
The present study is aimed to implementing and optimiz-
ing a protocol for the extraction of RNA from different 
components of skin biopsy to generate transcriptomics 
data. The skin is innervated by sensory nerve fibers origi-
nating from the primary sensory neurons of dorsal root 
ganglia, and their degeneration inversely correlates with 
the severity of the peripheral neuropathy and the risk of 
developing neuropathic pain [15, 16]. Our hypothesis is 
that a modification at the transcriptome level could occur 
in the neighbouring environment of skin nerve fibers 
involved in the transduction of nociception, including 
Schwann cells, endothelial, interstitial, and inflamma-
tory cells, as a consequence of pathology. According to 
this hypothesis, we can speculate that transcriptomic 
data generated in this study using this protocol will allow 
identifying target genes and expression markers of the 
cellular components involved in the disease (e.g. neu-
ropeptides acting on neuronal and non-neuronal target 
cells). As a proof-of-concept, in our data we compared 
the expression levels of skin-specific genes (COL17A1, 
DMKN and KRT10) among skin compartments and 
whole blood as non-skin tissue, demonstrating a sig-
nificant difference. To further explore our hypothesis, 
we considered the ELF in the protocol and in the analy-
sis, because it is the component of greatest interest for 
detecting a transcriptional signature of peripheral neu-
ropathy since it is enriched of intraepidermal nerve fibers 
selectively degenerated in the disease and which den-
sity is routinely counted in skin biopsy to diagnose the 
disease.
Our protocol was optimized to reduce the impact of 
several events that affect the quality and the yield of RNA 
such as the activation of nucleases induced by the exci-
sion of the tissue [12], the presence of RNase and other 
deleterious components in aqueous environment when 
specimen is defrosted and in the aqueous reagents for 
sample preparation [7, 12], temperature changes from 
4 °C to room temperature steps [9] and to higher temper-
atures generated by the energy of the laser during LMD. 
In Fig. 4 we reported a flowchart summarizing the steps 
of the protocol from skin biopsy collection to quality 
control steps on RNA sequencing raw data.
To preserve the RNA integrity, different solutions were 
evaluated. Brown et al. [10] suggested the use of high-salt 
buffer solutions during the immunostaining of rat brain 
sections to obtain high yield and quality RNA from cells 
isolated by microdissection. The authors concluded that 
an overnight incubation in 2M NaCl or  RNALater® Solu-
tion resulted in less degradation, although they preferred 
to avoid the use of the  RNALater® Solution because it 
affects the immunolabeling downstream process. How-
ever, in our protocol the use of  RNALater® Solution did 
not affect samples when they were examined for stand-
ard histological criteria [17], therefore we immersed the 
fresh biopsy in the solution to minimize the RNA degra-
dation and the alteration of the expression profile imme-
diately after the biopsy collection. In addition, this step 
performed in the first phases of the protocol facilitates 
the collection of specimens from distant laboratories 
in the context of multicenter studies allowing the ship-
ment of specimens immersed in  RNALater® Solution 
under refrigerated condition. Our protocol was set up 
on 7  days of  RNALater® Solution incubation; however, 
few hours up to 1 month at 4 °C did not impact the RNA 
preservation.
LMD allows isolating homogenous tissues from which 
nucleic acids and proteins can be extracted for down-
stream analyses [6]. A good sample preparation starting 
Fig. 3 RNA expression of genes enriched in skin. Graph of  log2 
FPKM (Fragments Per Kilobase Million) values of three genes known 
to be enriched in skin tissue (COL17A1: Collagen Type XVII Alpha 1 
Chain; DMKN Dermokine; KRT10: Keratin 10) evaluated in each skin 
compartments and in whole blood (ELF enriched layer of fibers, G 
glands, D dermis, WS whole section, WB whole blood). Bar plot shows 
the mean ± standard error of the mean. Statistical significance is 
reported for each skin compartments compared to whole blood (**p: 
0.0013; ***0.0001 ≤ p ≤ 0.0007; ****p < 0.0001)
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with its inclusion in embedding medium, the cut of thin 
sections, and the staining to visualize tissue components 
are fundamental for the efficiency of dissection. Skin is 
the outermost organ of the mammalian with the main 
roles of functional barrier, temperature regulation, pre-
vention of body water loss and protection of internal tis-
sues and organs against external physical, chemical and 
biological insults [18–21]. It is a complex stratified tissue 
in which different cells organized in layers can be dis-
tinguished by expression markers and morphology [22] 
using immunolabeling and/or histological staining. The 
specific characteristics of the samples can be preserved 
choosing among different available embedding condi-
tions. One of the most used tissue preservation method is 
the formalin fixation and paraffin embedding which allow 
the best morphological identification of tissue compart-
ments [12]. In clinical practice and in pathological stud-
ies, formalin and paraffin fixations are commonly used, 
but they are not recommended for our aim because they 
chemically alter the nucleotides inducing nucleic acids 
fragmentation and lowering the quality of RNA [12]. For 
this reason, we opted for the cryopreservation of the tis-
sue embedding the specimen with Killik cryostat in OCT 
medium. To overcome the difficulty of skin cryosection 
due to its tendency to thaw after freezing and to soften 
because of the high degree of fatty tissue, we facilitated 
the cut scrolling a little amount of liquid nitrogen over 
the sample positioned on the object holder of the cry-
ostat every two cryosected sections to harden the biopsy 
and to decrease its temperature.
H&E staining was performed following the protocol 
published by Yee  and colleagues [9] with some modifica-
tions, as reported in “Materials and methods”. As previ-
ously reported in different protocols of RNA extraction 
from pancreas, lymph node, breast and others tissues, 
the treatment with RNase Inhibitors minimized the deg-
radation of RNA during immunohistochemistry and/or 
histological staining, during RNA extraction process and 
after RNA isolation [7, 10, 12]. For this reason, we added 
 RNasin® Plus RNase Inhibitor (Promega, Madison, WI, 
USA) in H&E solutions [10, 12], but not in final eluted RNA 
to avoid interference during libraries processing. Compar-
ing with the original staining procedure, we performed an 
efficient coloration of the skin section in approximately 
3  min instead of 5, diluting colored solution and adding 
inhibitors.
Fig. 4 Workflow of the steps of the protocol. The flowchart summarizes the steps of the protocol from the skin biopsy collection to the quality 
control check on raw data generated from sequencing
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The hardness of the skin, mainly composed by 
keratinocytes and cornified layers, increases the risk of 
flaking of the outer epidermal layers during the laser cap-
ture microdissection. A specific balance between the cut-
ting parameters of power, thickness, and velocity of the 
laser beam were adjusted to avoid the tissue break and to 
accelerate the cutting process limiting the RNA degrada-
tion due to the high temperature of laser.
Despite the introduction of several optimization steps 
to reduce RNA degradation, some samples did not fulfill 
Illumina recommendations regarding the RNA input for 
the RNA sequencing profiling (amount > 20  ng for sam-
ples with  DV200 ≥ 70%, Additional file 1: Table S1). How-
ever, we proceed with library preparation, and in 80% of 
samples we were able to generate high quality libraries 
for sequencing, while for the remaining 20% we did not 
obtain enough cDNA to perform hybridization (Addi-
tional file  1: Table  S1). We observed a positive correla-
tion between the input material and the cDNA amount 
(Fig.  2a). The different yield of cDNA among samples 
impacted on the multiplexed modality of the hybridiza-
tion since we were not able to hybridize 200 ng of each 
sample in all pool according to the manufacturer’s proto-
col. As expected, the yield of library was directly propor-
tional to the amount of cDNA pooled (Fig. 2b). Despite 
the encountered limitations, the generated libraries ful-
filled the requested quality and quantity parameters for 
sequencing, confirming that it is possible to generate 
high-quality libraries even starting with 17  ng of initial 
RNA.
The quality control steps of RNA sequencing data 
are critical to provide additional perspective into the 
quality of downstream results and to define the reli-
ability and reproducibility of raw data [2]. As reported 
in Additional file 2: Figures S1A, B, the base sequence 
quality by cycle was higher than the common consid-
ered threshold of Q30 which is equivalent to the proba-
bility of an incorrect base call 1 in 1000 times. A typical 
shape of the Q score trend was observed with a smaller 
set of quality values observed at the first cycles reflect-
ing the adjustment in the calibration of the sequencer 
while the drop of qualities at the end was a direct con-
sequence of the final saturation and of the sequencing’s 
chemistry. The quality of base call was not influenced 
by tissue compartments (Additional file 2: Figures S1A) 
and by flow cells used (Additional file  2: Figures  S1B), 
confirming the absence of batch effects caused by the 
nature of the samples and/or by the technique. More-
over, the uniformity of the samples of the same tissue 
compartment sequenced in different flow cells allowed 
to merge data and to perform downstream analyses 
without any impact on the quality of the entire experi-
ment. We next performed a PCA analysis to confirm 
that samples of the same tissue clustered together more 
than different tissues from same individual (Additional 
file 4: Figure S3), and to identify potential outliers and 
batch effect. As a matter of fact, we identified two sam-
ples (S7d and S11g) that were deemed outliers and they 
were excluded from downstream analysis (Additional 
file 4: Figure S3).
The percentage of mapped reads was used as an addi-
tional indicator of the overall capture efficiency [23]. 
Although the percentage of mapped reads across samples 
were high and homogeneous, even though libraries were 
generated in limiting conditions of quality and quan-
tity of the input material, a positive trend was observed 
between the degree of degradation and the capturing effi-
ciency (Additional file 5: Figure S4B).
Conclusions
In the present manuscript we describe an implemented 
and optimized protocol that allows obtaining reliable 
RNA sequencing data from fresh-frozen skin human 
biopsy by combining the LMD technology to NGS tech-
nology. Crucial steps of optimization of the protocol were 
an initial treatment of the specimens with  RNALater® 
preserving solution, the storage of the specimen at low 
temperature and using liquid nitrogen flow during cryo-
section, the addition of RNase inhibitors during H&E 
staining, and the time reduction of the staining proce-
dure. The successful parameters of quality control and 
the overall homogeneity among the different samples, 
confirm that the protocol was effective in extracting RNA 
suitable for transcriptomic approach. Mostly, the imple-
mented protocol allows generating expression profile 
starting with degraded RNA, and in particular in condi-
tions in which the quality and quantity of extracted RNA 
was below suggested thresholds for the enrichment pro-
tocol. Downstream differential expression analysis will 
allow comparing the transcriptome in specific skin com-
partments of different subgroups of neuropathic patients 
(e.g. painful and painless) and healthy controls. Lastly, 
the implemented protocol can be used also in other dis-
eases that require to collect biopsies from skin or other 
tissues, as well as in collaborative projects that require 
sampling from different centers, offering the opportunity 
to enlarge sample size for transcriptomics studies.
Materials and methods
Subject recruitment and Ethics Committee
Skin biopsies from 14 individuals (4 subjects affected 
by painful and 4 by painless idiopathic sensory neu-
ropathy and 6 age- and sex-matched healthy controls) 
were collected at the IRCCS Foundation “Carlo Besta” 
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Neurological Institute in Milan in agreement with the 
approval of the local Ethics Committee (Ethics Com-
mittee Number 03, 11/12/2013). Written consent was 
obtained from all recruited participants.
Skin biopsy collection and preservation
Skin biopsies were taken using a disposable 3-mm punch 
10 cm above the lateral malleolus under sterile condition 
after topic anesthesia with spray ice [24, 25]. Immediately 
after the sampling, the biopsy was submerged in 1.5  ml 
of  RNALater® Solution (Applied Biosystems, Foster City, 
CA, USA) and stored for 1 week at 4 °C to allow the per-
meation of the solution into cells resulting in RNA sta-
bilization (Fig.  4) [26]. The following step was a double 
rinse of the biopsy in refrigerated DPBS 10× without 
Calcium and Magnesium (Sigma-Aldrich, St. Louis, MO, 
USA). The sample was then included in Killik cryostat 
embedding OCT medium (Bio Optica, Milan, Italy), 
snap-frozen and stored in liquid nitrogen for at least 
1 week before proceeding to the next steps. RNase con-
tamination was avoided by previously cleaning surfaces 
and instruments with  RNaseZap® Solution (Thermo 
Fisher Scientific, Waltham, MA, USA).
Cryosection
The frozen samples were cryosected using the Leica 
cryostat (Leica Mikrosysteme Vertrieb, Wetzlar, Ger-
many) set at − 20  °C. The blade was previously cleaned 
with  RNaseZap® Solution. Around 20–30 slices of 20 μm 
of thickness were transferred on Pen Membrane Glass 
Slides (Leica Mikrosysteme Vertrieb, Wetzlar, Germany) 
previously activated by exposure to UV light for 20 min. 
Every two cryosected slides a little amount of liquid 
nitrogen was scrolled over the sample positioned on the 
object holder to harden it. The tissue slices on the glass 
were stored at − 80 °C before proceeding with the histo-
logical coloration.
Histological coloration
In order to recognize the skin layers of the biopsy, a fast 
hematoxylin and eosin staining was performed on the 
slices with slight modifications of the protocol published 
by Yee  and colleagues [9]. Staining was performed after 
removing the glass slides from − 80 °C and leaving them 
at room temperature for few minutes to dry. Tissues were 
dehydrated in 70% ethanol (prepared in DEPC water) 
for 20  s. For the hematoxylin staining, 500  μl of diluted 
1:2 hematoxylin solution in ethanol added with 1  U/μl 
 RNasin® Plus RNase Inhibitor (Promega, Madison, WI, 
USA) shortly before the use [10, 12], was used for 10  s. 
After a 10 s wash in DEPC water and an additional 10 s 
wash in 70% ethanol, the slices were stained for 2 s with 
250 μl of diluted 1:2 eosin solution in ethanol containing 
1 U/μl  RNasin® Plus RNase Inhibitor (Promega, Madison, 
WI, USA) shortly before the use. Instead of staining the 
glass slides by immersion, they were horizontally posi-
tioned on the bench and drops of colored solutions were 
added over. Subsequently, after a 10 s wash in DEPC water 
and a 10 s wash in 70% ethanol, the tissues on glass slides 
were dried at room temperature for few minutes and 
then stored at − 80  °C before proceeding with the laser 
microdissection.
Laser microdissection
The colored slides were removed from − 80  °C and 
left few minutes at room temperature to dry before 
being placed on a Leica Microdissection system 
LMD6000  (Leica Mikrosysteme Vertrieb, Wetzlar, Ger-
many). To minimize the damage of the laser on the tis-
sue, the focus and the energy of the laser were modified 
for each slide. Cut sections fell by gravity in the tube and 
were stored at − 80  °C before proceeding with the RNA 
extraction.
Type and dimension of microdissected tissues
From the 20–30 colored tissue slices of each subject, four 
different microdissected skin components were collected: 
(a) the enriched layer of fibers extending from the epider-
mis to 200–300 μm deep into the biopsy; (b) the glands; 
(c) the dermis, and (d) the whole section. No relative 
percentage of cell types was measured, and no specific 
recognition was performed to determine the differences 
between exocrine and endocrine glands. Moreover, fat 
cells were not removed from the glandular tissue during 
the microdissection.
RNA extraction and DNase treatment
Extraction of total RNA was performed using the 
 PicoPure® RNA Isolation Kit (Thermo Fisher Scientific, 
Waltham, MA, USA). As first step, the addition of extrac-
tion buffer was performed with 100  μl for each tissue 
except for glands, for which 50  μl were added to avoid 
an excessive dilution of RNA due to the small amount of 
microdissected material. An on-column DNase digestion 
was performed treating the RNA bound to the column 
for 20 min with 5 μl of DNase I diluted in 35 μl of RDD 
buffer (RNase-Free DNase Set, Qiagen, Valencia, CA) 
to remove genomic DNA. 20 μl of RNase Nuclease free 
water for all tissues, except for glands for which 15 μl was 
used, were pipetted directly onto the membrane of the 
purification column to elute the RNA into an RNase free 
tube. RNA was then stored at − 80 °C.
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Quality control and concentration measurements 
of the extracted RNA
RNA quality was estimated by microfluidic capillary elec-
trophoresis by running 1 μl of each sample on an Agilent 
2100 Bioanalyzer Instrument (Agilent Technologies, Cal-
ifornia, United States) using the Agilent RNA 6000 Pico 
Kit. The RNA degradation was evaluated measuring the 
percentage of RNA fragments longer than 200 nucleo-
tides and the RNA Integrity Number. The concentration 
of RNA was measured by fluorometric quantitation using 
the  Qubit® RNA HS Assay kit on  Qubit® 2.0 Fluorometer 
(Thermo Fisher Scientific, Waltham, MA, USA).
Libraries preparation and sequencing
RNA was processed for library preparation using the 
 TruSeq® RNA Access Library Preparation Kit (Illumina, 
San Diego, CA, USA) that allows generating libraries 
starting from degraded and low yield RNA. Briefly, the 
first and second cDNA strands were synthetized from 
input RNA in order to be adaptor-tagged, labeled and 
amplified. CDNA from each sample was then pooled. 
Pooling strategy was decided considering tissues and 
subjects uniformity. Each pool contained two to four 
samples of the same tissue and included both patients 
and controls. Pooled samples were enriched by a double 
step of probes hybridization. The enriched targets were 
captured by streptavidin labelled beads, cleaned up and 
amplified to obtain the final multiplexed libraries. Librar-
ies quality was checked for fragments distribution using 
Agilent DNA High Sensitivity Kit on an Agilent 2100 Bio-
analyzer Instrument (Agilent Technologies, Santa Clara, 
CA, USA) and quantified by  Qubit® DNA HS Assay kit 
on a  Qubit® 2.0 Fluorometer  (Thermo Fisher Scientific, 
Waltham, MA, USA). The libraries were then sequenced 
on an Illumina  HiSeq® 2500 platform  (Illumina®) with a 
rapid paired-end sequencing (2 × 101  bp). The protocol 
for libraries generation was executed step by step except 
for the adjustment of cDNA amount used for hybridiza-
tion (details shown in the results section).
Quality control analysis of RNA sequencing
The quality control check on raw sequenced data was 
assessed with FastQC (version 0.11.3) in a non-inter-
active mode [27]. The obtained numeric values were 
aggregated to generate a unique plot of base sequence 
quality averaging the score and the standard deviation of 
sequenced bases stratified for tissue compartments and 
flow cells. Since some of the samples had an amount of 
reads > 45 million compared to the median value, we per-
formed a down sampling step, reducing their amount to 
35 million using the seqtk software (version 0.2.2). Reads 
were then trimmed and short reads were removed using 
Skewer 0.2.2 tool [28]. We carried out Principal Compo-
nent Analysis to assess overall grouping of data accord-
ing to tissue type and to detect potential outliers. PCA 
was applied to the matrix of down-sampled log10-trans-
formed raw counts. Pair-end reads were aligned using 
STAR software (version 2.5.2b) [29] against the GRCh37 
reference genome. Quantification of genes and isoforms 
was performed with RSEM software version 1.3.3 [30] 
using the ENSEMBL GRCh37.87 annotation GTF file.
Statistical analyses
Statistical data and graphs were performed in GraphPad 
Prism Software, version 5.04. Mean values and standard 
deviations are presented for different measures. Cor-
relation analysis was carried out with the Spearman’s r 
coefficient calculation. All the other data were analyzed 
statistically by the Mann–Whitney nonparametric test. 
Differences were considered statistically significant when 
the p value was ≤ 0.05.
Additional files
Additional file 1: Table S1. Summary of characteristics of subjects and 
skin components. Quality parameters on extracted RNA (RIN and  DV200), 
RNA input amount used for library preparation, RNA concentration of 
pre-pooled samples, amount of hybridized cDNA, final concentration of 
libraries and million of reads sequenced for sample are shown. Subjects 
are indicated by the sample ID. Samples from number 1 to 8 were patients 
and from number 9 to 14 were healthy controls. Samples pooled together 
are indicated by the same capital letter (from A to O) in the pool row. The 
samples that did not reach the requested amount for hybridization were 
excluded from the experiment (marked as “X”).
Additional file 2: Figure S1. Base sequence quality score. The two graphs 
show the Phred quality score (Q score) on y axis across all sequenced 
based on x axis at each position in the FASTQ file for the different skin 
layers, flow cells (FC) and reads (1 and 2). All the values were reported as 
mean ± standard deviation. A) Q score distribution across different tissues 
(ELF: enriched layer of fibers, G: glands, D: dermis and WS: whole section); 
B) Q score distribution across the different FC used for sequencing.
Additional file 3: Figure S2. Density plot. Density plot of log10-trans-
formed reads counts of protein coding genes is reported. The global trend 
shows a distribution close to a Gaussian distribution and a similarity across 
all samples. ELF: enriched layer of fibers, G: glands, D: dermis and WS: 
whole section.
Additional file 4: Figure S3. Principal Component Analysis (PCA). PCA 
was performed on log10-transformed down-sampled reads counts. The 
first 3 principal components (PCs), explaining the 43% of the variance, are 
shown. For each sample, the color and the label indicate the tissue (elf: 
enriched layer of fibers in pink; g: glands in blue; d: dermis in green and 
ws: whole section in yellow), while the number is related to the subject ID.
Additional file 5: Figure S4. Percentage of uniquely mapped reads. 
A) Uniquely mapped reads reported in percentage for each tissue (ELF 
enriched layer of fibers; G glands; D dermis and WS whole section). Scatter 
dot plot shows the mean ± standard deviation and each dot represents 
the value of a single sample. Numeric values are reported for each tissue 
as mean ± standard deviation. B) Relationship between the uniquely 
mapped reads and RNA degradation expressed as  DV200 (p: 0.013, beta: 
0.11 and  r2: 0.15). Each dot represents one sample.
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